Research Article
The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B
Table 2
Clinical characteristics of the CHB nonsignificant liver fibrosis group (S0-1) and significant liver fibrosis (S2-4) cases (
).
| Clinical characteristics | S0-1 | S2-4 | |
| Male/female | 16/9 | 21/12 | 1.0 | Age (years old) | | | 0.064 | Blood cell counts (109/L) | | | 0.118 | Hemoglobin (g/L) | | | 0.224 | Blood platelet (109/L) | | | 0.04 | ALT (U/L) | | | 0.107 | AST (U/L) | | | 0.109 | γ-GT (U/L) | | | 0.123 | ALP (U/L) | | | 0.09 | T-Bil (μmol/L) | | | 0.761 | D-Bil (μmol/L) | | | 0.807 | TP (g/L) | | | 0.148 | ALB (g/L) | | | 0.291 | TC (U/L) | | | 0.889 | TG (U/L) | | | 0.065 | AFP | | | 0.08 | INR | | | 0.233 | HBV-DNA (107 U/L) | | | 0.743 | HBeAg-positive rate (%) | 60% | 72% | 0.399 |
|
|